Positive Activities for Asian American Cancer Patients and Caregivers
NCT ID: NCT05203614
Last Updated: 2024-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2021-11-30
2024-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
NCT06782581
Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers
NCT04810052
Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors
NCT02946619
Experience of Brain Tumor Caregivers
NCT00352820
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
NCT05904782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The overall objective of this project is to design and test the feasibility of two positive activities, household contribution and outside contribution, to increase quality of life in AA cancer patients.
Secondary Objectives:
Aim 1: To assess the acceptability and feasibility of household and outside contribution positive activities for AAs through a mixed qualitative and exploratory quantitative investigation.
Aim 2: To use the qualitative and quantitative data from Aim 1, in collaboration with the mentorship team, AA community members, and clinicians, to develop one or both positive activity intervention(s) (i.e., household or outside contribution) specifically for AA cancer patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Household Contribution
Do something thoughtful or nice for your caregiver that would provide them with tangible support
Household Contribution
Questionnaires
Outside Contribution
Do something outside your home/household that contributes to the larger society
Outside Contribution
Questionnaires
Control
Keep track of your daily activities
Control
Questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Household Contribution
Questionnaires
Outside Contribution
Questionnaires
Control
Questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* males or females ages 25-75 years
* within 1 year of any cancer diagnosis
* actively undergoing systemic therapy (e.g., chemotherapy, radiation)
* able to identify a caregiver (e.g., spouse) who lives in the same household and consents to participate in the study,
* able to read, write, and speak English (i.e., English proficient; EP),
* access to internet, computer/phone, and web browser.
* identifies as AA,
* patient considers them to be caregiver, -
* EP,
* access to computer/phone, internet, and web browser.
Exclusion Criteria
* inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status),
* major thought disorder (e.g., schizophrenia or bipolar \[patient records or
* unwilling or unable to participate in the study for any reason,
* under the age of 18.
25 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LI Qian
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-12848
Identifier Type: OTHER
Identifier Source: secondary_id
2021-0998
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.